These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients. Potenza L; Vallerini D; Barozzi P; Riva G; Forghieri F; Zanetti E; Quadrelli C; Candoni A; Maertens J; Rossi G; Morselli M; Codeluppi M; Paolini A; Maccaferri M; Del Giovane C; D'Amico R; Rumpianesi F; Pecorari M; Cavalleri F; Marasca R; Narni F; Luppi M Blood; 2011 Nov; 118(20):5416-9. PubMed ID: 21931119 [TBL] [Abstract][Full Text] [Related]
17. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Ibrahim AS Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879 [TBL] [Abstract][Full Text] [Related]
18. COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic. Chandley P; Subba P; Rohatgi S Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016154 [TBL] [Abstract][Full Text] [Related]
19. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review. Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGFR Signaling Protects from Mucormycosis. Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM mBio; 2018 Aug; 9(4):. PubMed ID: 30108171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]